Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China OK's ChemChina's $43 Billion Acquisition of Switzerland's Syngenta

publication date: Apr 12, 2017
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China's Ministry of Commerce approved the $43 billion takeover of Switzerland's Syngenta by ChemChina, a state-owned company. The transaction is the largest acquisition of a foreign entity in any sector by a China company. Its MOFCOM approval shows that China is ready to allow large amounts of China capital to move overseas, given the right opportunity. Syngenta produces agrochemicals and seeds, and its biotech division conducts genomic research. ChemChina is a specialty chemical company with a major focus in agrochemicals. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...